Free Trial

Best Stocks Under $2 Right Now

It can be difficult to find a deal in the stock market regardless of current market conditions. For the last decade, stocks have traded well above historical average P/E ratios. Fortunately there are still a handful of undervalued stocks in corners of the market that most investors ignore. This page lists cheap stocks that have a share price of $2.00 (2 dollars) or less and consisently-receive "buy" and "strong buy" ratings from Wall Street's top-rated research analysts.

Denison Mines stock logo

1. Denison Mines NYSEAMERICAN:DNN

$1.24 -0.06 (-4.62%)
Closing price 04/3/2025 04:10 PM Eastern
Extended Trading
$1.25 +0.01 (+0.40%)
As of 05:52 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Denison Mines Corp. engages in the acquisition, exploration, and development of uranium bearing properties in Canada. Its flagship project is the Wheeler River uranium project covering an area of approximately 300,000 hectares located in the Athabasca Basin region in northern Saskatchewan. More about Denison Mines

Market Capitalization
$1.11 billion
P/E Ratio
-124.00
Consensus Rating
Buy
Consensus Price Target
$3.00 (+141.9% Upside)
Volume
61.92 million shares
Average Volume
26.54 million shares
Stardust Power stock logo

2. Stardust Power NASDAQ:SDST

$0.50 -0.03 (-5.84%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.51 +0.00 (+0.79%)
As of 06:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Stardust Power Inc is a vertically-integrated lithium refinery that engages in producing battery-grade lithium. The company was founded in 2022 and is based in Greenwich, Connecticut.

Market Capitalization
$26.66 million
Consensus Rating
Buy
Consensus Price Target
$5.11 (+912.4% Upside)
Volume
208,491 shares
Average Volume
359,296 shares
Today's Range
$0.48
$0.54
OS Therapies stock logo

3. OS Therapies NYSE:OSTX

$1.54 +0.03 (+1.99%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.60 +0.06 (+3.96%)
As of 06:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

OS Therapies Incorporated, a clinical stage biopharmaceutical company, focuses on the identification, development, and commercialization of treatments for osteosarcoma and other solid tumors in the United States. More about OS Therapies

Market Capitalization
$33.52 million
Consensus Rating
Buy
Consensus Price Target
$18.00 (+1,068.8% Upside)
Volume
357,045 shares
Average Volume
506,543 shares
Today's Range
$1.46
$1.80
enCore Energy stock logo

4. enCore Energy NASDAQ:EU

$1.18 -0.09 (-7.09%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.23 +0.05 (+4.24%)
As of 05:14 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

enCore Energy Corp. engages in the acquisition, exploration, and development of uranium resource properties in the United States. More about enCore Energy

Market Capitalization
$236.71 million
P/E Ratio
-4.21
Consensus Rating
Buy
Consensus Price Target
$4.38 (+270.8% Upside)
Volume
2.97 million shares
Average Volume
1.44 million shares
Quince Therapeutics stock logo

5. Quince Therapeutics NASDAQ:QNCX

$1.26 -0.06 (-4.55%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.22 -0.04 (-3.57%)
As of 04/3/2025 06:23 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Quince Therapeutics, Inc, a biopharmaceutical company, focuses on acquiring, developing, and commercializing therapeutics for patients with debilitating and rare diseases. More about Quince Therapeutics

Market Capitalization
$55.44 million
P/E Ratio
-1.02
Consensus Rating
Buy
Consensus Price Target
$8.00 (+534.9% Upside)
Volume
130,882 shares
Average Volume
244,626 shares
GeoVax Labs stock logo

6. GeoVax Labs NASDAQ:GOVX

$1.10 -0.08 (-6.78%)
As of 04/3/2025 04:00 PM Eastern

GeoVax Labs, Inc, a clinical-stage biotechnology company, develops human vaccines and immunotherapies against infectious diseases and solid tumor cancers using modified vaccinia ankara virus-like particle vaccine platform. More about GeoVax Labs

Market Capitalization
$11.14 million
P/E Ratio
-0.19
Consensus Rating
Buy
Consensus Price Target
$14.20 (+1,190.9% Upside)
Volume
436,895 shares
Average Volume
611,722 shares
Remove Ads
Cardiol Therapeutics stock logo

7. Cardiol Therapeutics NASDAQ:CRDL

$0.91 -0.01 (-1.09%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.93 +0.02 (+1.76%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Cardiol Therapeutics Inc, a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of heart diseases. More about Cardiol Therapeutics

Market Capitalization
$75.17 million
P/E Ratio
-2.33
Consensus Rating
Buy
Consensus Price Target
$8.40 (+823.1% Upside)
Volume
205,795 shares
Average Volume
383,791 shares
Reviva Pharmaceuticals stock logo

8. Reviva Pharmaceuticals NASDAQ:RVPH

$0.56 +0.00 (+0.63%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.56 +0.00 (+0.09%)
As of 05:26 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Reviva Pharmaceuticals Holdings, Inc, a biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, inflammatory, and cardiometabolic diseases. More about Reviva Pharmaceuticals

Market Capitalization
$18.84 million
P/E Ratio
-0.51
Consensus Rating
Buy
Consensus Price Target
$10.00 (+1,674.6% Upside)
Volume
806,140 shares
Average Volume
1.09 million shares
Rezolve AI stock logo

9. Rezolve AI NASDAQ:RZLV

$1.45 +0.06 (+4.32%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.46 +0.01 (+0.69%)
As of 06:15 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rezolve Ai Ltd. operates in the mobile commerce industry with its cutting-edge engagement platform powered by artificial intelligence and machine learning. More about Rezolve AI

Market Capitalization
$249.67 million
Consensus Rating
Buy
Consensus Price Target
$6.00 (+313.8% Upside)
Volume
2.95 million shares
Average Volume
5.17 million shares
Today's Range
$1.27
$1.49
Nkarta stock logo

10. Nkarta NASDAQ:NKTX

$1.71 -0.20 (-10.47%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.72 +0.02 (+0.88%)
As of 05:37 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Nkarta, Inc, a clinical-stage biopharmaceutical company, develops and commercializes natural killer cell therapies for cancer and autoimmune disease treatment. More about Nkarta

Market Capitalization
$135.53 million
P/E Ratio
-0.91
Consensus Rating
Buy
Consensus Price Target
$14.86 (+768.8% Upside)
Volume
1.09 million shares
Average Volume
1.09 million shares
Immunic stock logo

11. Immunic NASDAQ:IMUX

$1.05 -0.06 (-5.41%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.02 -0.03 (-2.38%)
As of 06:13 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Immunic, Inc, a biotechnology company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases in the United States and Germany. More about Immunic

Market Capitalization
$100.07 million
P/E Ratio
-0.85
Consensus Rating
Buy
Consensus Price Target
$12.67 (+1,106.3% Upside)
Volume
844,011 shares
Average Volume
609,551 shares
Remove Ads
Western Copper & Gold stock logo

12. Western Copper & Gold NYSE:WRN

$1.08 -0.02 (-1.82%)
As of 04/3/2025 04:00 PM Eastern

Western Copper & Gold Corp. operates as an exploration stage company, which engages in the acquisition, exploration, and future development of mineral resource properties. More about Western Copper & Gold

Market Capitalization
$220 million
P/E Ratio
-54.00
Consensus Rating
Buy
Consensus Price Target
$4.25 (+293.5% Upside)
Volume
376,655 shares
Average Volume
295,653 shares
PMV Pharmaceuticals stock logo

13. PMV Pharmaceuticals NASDAQ:PMVP

$1.00 -0.01 (-0.50%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.00 +0.01 (+0.50%)
As of 04/3/2025 04:05 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

PMV Pharmaceuticals, Inc, a precision oncology company, engages in the discovery and development of small molecule and tumor-agnostic therapies for p53 mutations in cancer. More about PMV Pharmaceuticals

Market Capitalization
$51.67 million
P/E Ratio
-1.00
Consensus Rating
Buy
Consensus Price Target
$5.50 (+452.8% Upside)
Volume
105,975 shares
Average Volume
274,313 shares
FibroBiologics stock logo

14. FibroBiologics NASDAQ:FBLG

$0.88 -0.06 (-6.56%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.91 +0.04 (+4.46%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

FibroBiologics, Inc operates as a cell therapy, regenerative medicine company. It is developing a pipeline of treatments and potential cures for chronic diseases using fibroblast cells and fibroblast-derived materials. More about FibroBiologics

Market Capitalization
$31.86 million
Consensus Rating
Buy
Consensus Price Target
$13.00 (+1,385.7% Upside)
Volume
197,192 shares
Average Volume
276,360 shares
Today's Range
$0.87
$0.95
Invivyd stock logo

15. Invivyd NASDAQ:IVVD

$0.55 -0.03 (-5.03%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.55 +0.00 (+0.55%)
As of 06:04 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Invivyd, Inc, a commercial-stage biopharmaceutical company, focuses on the discovery, development, and commercialization of antibody-based solutions for infectious diseases in the United States. More about Invivyd

Market Capitalization
$65.98 million
P/E Ratio
-0.28
Consensus Rating
Buy
Consensus Price Target
$7.89 (+1,334.1% Upside)
Volume
1.71 million shares
Average Volume
4.22 million shares
NRx Pharmaceuticals stock logo

16. NRx Pharmaceuticals NASDAQ:NRXP

$1.87 -0.14 (-6.97%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.88 +0.01 (+0.53%)
As of 04/3/2025 07:08 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

NRx Pharmaceuticals, Inc, a clinical-stage bio-pharmaceutical company, develops novel therapeutics for the treatment of central nervous system disorders, including suicidal depression, post-traumatic stress disorder, and chronic pain. More about NRx Pharmaceuticals

Market Capitalization
$31.63 million
P/E Ratio
-0.87
Consensus Rating
Buy
Consensus Price Target
$28.25 (+1,410.7% Upside)
Volume
170,640 shares
Average Volume
452,093 shares
Remove Ads
Lucid Diagnostics stock logo

17. Lucid Diagnostics NASDAQ:LUCD

$1.50 +0.03 (+2.04%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.54 +0.04 (+2.93%)
As of 04:05 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Lucid Diagnostics Inc operates as a commercial-stage medical diagnostics technology company in the United States. The company focuses on patients with gastroesophageal reflux disease (GERD) who are at risk of developing esophageal precancer and cancer, primarily highly lethal esophageal adenocarcinoma. More about Lucid Diagnostics

Market Capitalization
$136.13 million
P/E Ratio
-1.32
Consensus Rating
Buy
Consensus Price Target
$3.40 (+126.7% Upside)
Volume
596,934 shares
Average Volume
366,368 shares
HIVE Digital Technologies stock logo

18. HIVE Digital Technologies NASDAQ:HIVE

$1.48 -0.13 (-8.07%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.49 +0.01 (+0.68%)
As of 06:10 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

HIVE Digital Technologies Ltd. operates as a cryptocurrency mining company in Canada, Sweden, and Iceland. The company engages in the mining and sale of digital currencies, including Ethereum Classic, Bitcoin, and other coins. More about HIVE Digital Technologies

Market Capitalization
$243.59 million
P/E Ratio
-29.60
Consensus Rating
Buy
Consensus Price Target
$7.64 (+416.4% Upside)
Volume
9.10 million shares
Average Volume
5.80 million shares
Perspective Therapeutics stock logo

19. Perspective Therapeutics NYSE:CATX

$1.96 -0.09 (-4.39%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.94 -0.02 (-1.02%)
As of 04:00 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Perspective Therapeutics, Inc, together with its subsidiaries, develops precision-targeted alpha therapies (TAT) for oncology that treats cancer patients across multiple tumor types comprising metastatic disease. More about Perspective Therapeutics

Market Capitalization
$145.14 million
Consensus Rating
Buy
Consensus Price Target
$14.44 (+637.0% Upside)
Volume
1.18 million shares
Average Volume
1.00 million shares
Today's Range
$1.91
$2.04
Rani Therapeutics stock logo

20. Rani Therapeutics NASDAQ:RANI

$1.30 -0.09 (-6.47%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.23 -0.08 (-5.77%)
As of 05:29 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Rani Therapeutics Holdings, Inc operates as a clinical stage biotherapeutics company that develops orally administered biologics for patients, physicians, and healthcare systems in the United States. More about Rani Therapeutics

Market Capitalization
$74.48 million
P/E Ratio
-1.23
Consensus Rating
Buy
Consensus Price Target
$12.33 (+848.7% Upside)
Volume
245,756 shares
Average Volume
745,808 shares
ProQR Therapeutics stock logo

21. ProQR Therapeutics NASDAQ:PRQR

$1.27 -0.10 (-7.30%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.34 +0.06 (+5.12%)
As of 04/3/2025 06:15 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

ProQR Therapeutics N.V., a biotechnology company, focuses on the discovery and development of novel therapeutic medicines. More about ProQR Therapeutics

Market Capitalization
$144.14 million
P/E Ratio
-3.97
Consensus Rating
Buy
Consensus Price Target
$9.50 (+648.0% Upside)
Volume
419,517 shares
Average Volume
568,965 shares
Gain Therapeutics stock logo

22. Gain Therapeutics NASDAQ:GANX

$1.79 -0.10 (-5.29%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.88 +0.09 (+5.25%)
As of 04/3/2025 06:24 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Gain Therapeutics, Inc, a biotechnology company, develops novel small molecule therapeutics to treat diseases across various therapeutic areas. More about Gain Therapeutics

Market Capitalization
$47.48 million
P/E Ratio
-1.63
Consensus Rating
Buy
Consensus Price Target
$8.20 (+358.1% Upside)
Volume
208,004 shares
Average Volume
283,675 shares
Context Therapeutics stock logo

23. Context Therapeutics NASDAQ:CNTX

$0.72 +0.04 (+5.74%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$0.70 -0.02 (-3.20%)
As of 05:40 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Context Therapeutics Inc, a biopharmaceutical company, develops products for the treatment of solid tumors. Its lead program candidate is CTIM-76, an anti-Claudin 6 (CLDN6) x anti-CD3 bispecific antibody that is intended to redirect T-cell-mediated lysis toward malignant cells expressing CLDN6. More about Context Therapeutics

Market Capitalization
$64.50 million
P/E Ratio
-0.79
Consensus Rating
Buy
Consensus Price Target
$6.17 (+757.7% Upside)
Volume
2.02 million shares
Average Volume
398,411 shares
Aclaris Therapeutics stock logo

24. Aclaris Therapeutics NASDAQ:ACRS

$1.49 -0.05 (-3.25%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.50 +0.01 (+0.34%)
As of 04/3/2025 04:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Aclaris Therapeutics, Inc a clinical-stage biopharmaceutical company, engages in the development of novel drug candidates for immune-inflammatory diseases in the United States. More about Aclaris Therapeutics

Market Capitalization
$160.80 million
P/E Ratio
-2.87
Consensus Rating
Buy
Consensus Price Target
$11.67 (+683.0% Upside)
Volume
805,468 shares
Average Volume
1.17 million shares
Compass Therapeutics stock logo

25. Compass Therapeutics NASDAQ:CMPX

$1.60 -0.09 (-5.03%)
Closing price 04/3/2025 04:00 PM Eastern
Extended Trading
$1.59 -0.01 (-0.93%)
As of 05:23 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Compass Therapeutics, Inc, a clinical-stage oncology-focused biopharmaceutical company, engages in developing antibody-based therapeutics to treat various human diseases in the United States. More about Compass Therapeutics

Market Capitalization
$221.94 million
P/E Ratio
-4.34
Consensus Rating
Buy
Consensus Price Target
$11.63 (+624.3% Upside)
Volume
1.91 million shares
Average Volume
805,499 shares